AMANDA VANDER WOUDE: Open Payments
NPI 1437881059 · NAMPA, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$590 in 26 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $590
Food & beverage: $510Education: $80
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $257 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $102 |
| Galderma Laboratories, L.P. | 3 | $64 |
| Organon LLC | 4 | $46 |
| UCB, Inc. | 2 | $45 |
| Janssen Biotech, Inc. | 2 | $31 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
| Incyte Corporation | 1 | $20 |
Products named: SKYRIZI, RINVOQ, NEMLUVIO, Bimzelx, TREMFYA, XOLAIR, ILUMYA, OPZELURA.
Industry payments across ID — which companies pay providers there.
